The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Market Cap	9.13B
Revenue (ttm)	11.80B
Net Income (ttm)	632.83M
Shares Out	31.24M
EPS (ttm)	20.25
PE Ratio	14.42
Forward PE	n/a
Dividend	6.30 (2.15%)
Ex-Dividend Date	Oct 27, 2025

Volume	16,203
Average Volume	25,042
Open	295.00
Previous Close	293.30
Day's Range	292.00 - 295.00
52-Week Range	267.00 - 334.80
Beta	0.16
RSI	39.07
Earnings Date	Nov 11, 2025

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2024, DSE:IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.